Scientific Plenary Meeting of the MINA-CM Project: Achievements of 2023 and Visions for 2024 in the Field of Neurotechnology

On January 22nd, the MINA-CM project held its annual scientific plenary meeting, marking a significant milestone in bringing together experts from various fields in the realm of neurotechnology with a special focus on health and its social impact. The project, of which the Innovation Unit is a part, consists of 13 research groups and 9 associated groups.

Dr. Julio Mayol, PI of the Research Group I,C,F, and N at IdISSC, presenting CHATBOT MINA CONNECT.

The plenary featured prominent participation from the principal investigators of the various groups comprising the MINA-CM consortium, representatives from academia, research, clinical practice, patient associations, caregivers and family members, social care entities, as well as companies and promoters of entrepreneurship and innovation.

Professor Fivos Panetsos, UCM. IdISSC, PI of the Neurocomputing and Neuro-robotics group

During the conference, the project stakeholders shared the achievements and activities carried out in 2023, as well as the strategic actions to be developed in 2024.

Among them are:

-Given the prominence of patients within the project, establish an ongoing dialogue aimed at uncovering “Unmet Needs” that should be studied and become part of the project’s actions.

-Study how to expand contacts with other patient associations.

-Offer scientific and technological services to society.

-Address new challenges: study whether there is a relationship between diseases such as Parkinson’s, Alzheimer’s, and macular degeneration.

Laura Carrasco, Director of Parkinson Madrid Association

The MINA-CM project is establishing itself as a true ecosystem where academic excellence, clinical expertise, social commitment, and business agility converge. This comprehensive approach enables the effective tackling of pressing challenges in the field of neurotechnology and makes a significant contribution to scientific and social progress.

José Antonio Otero, technician at the Macula-Retina Association

For more information about the MINA-CM project and its activities, please visit

About MINA-CM: The consortium consists of groups from academia and research, clinical settings, patient associations, caregivers and families, social care entities, companies, and promoters of entrepreneurship and innovation.

There are 13 research groups and 9 associated groups that contribute to the social and economic translation dimension.

Bookmark the permalink.

Comments are closed.